dihexa pnb-0408 human trial | c-Met chemical | CAS 1401708-83-5 dihexa human studies clinical trials

Scientists analyze the biological impact through BPC-157 studies

Until well-designed human clinical trials are published, any claims about BPC-157s efficacy remain speculative

A clear reagent reference reduces ambiguity when results shift between runs, helping investigators separate biological differences from procedural differences

After IM injections of 20, 100, and 500 g/kg of BPC157 in rats and 6, 30, and 150 g/kg of BPC157 in beagles, plasma BPC157 reached its peak rapidly (within 9 min)

These pathways are closely associated with c-MET amplification, tumor drug resistance, and malignant phenotypes [7]

Together they outperform either alone